EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion

Fatima Zahra Samet Bouhaik, Ilenia Monaco, Mounia Sedrati, Alix Bouvet, Benedicte Gervais, Valeria Trivelloni, Yassine Bencharef, Fouad Mohammed Sekkal, Dario Bottigliero iD

Journal of Cardiovascular Development and Disease · 19.08.2026 · 13 (8) · 397

DOI: 10.3390/jcdd13080397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 19.08.2026. Verfasst von Fatima Zahra Samet Bouhaik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systolic anterior motion (SAM) of the mitral valve can occur either in association with or in the absence of hypertrophic obstructive cardiomyopathy (HOCM). SAM induces dynamic left ventricular outflow tract obstruction (LVOTO) and, in the majority of cases, is associated with a substantial degree of mitral regurgitation (MR) that significantly impacts patient morbidity and mortality. This narrative review explores the contemporary understanding of the pathophysiology, diagnosis, and management of SAM, focusing particularly on surgical strategies and the novel therapeutic class of cardiac myosin inhibitors. Extended septal myectomy remains the gold-standard treatment for HOCM-related SAM, yielding superior long-term outcomes compared to alcohol septal ablation (ASA). Advanced imaging modalities, including three-dimensional transesophageal echocardiography (3D-TEE), enable precise pre-operative characterization of the mitral valve apparatus. Some patients may benefit from septal reduction strategies while concomitant mitral valve interventions are generally reserved for highly selected cases with intrinsic valve pathology or persistent residual SAM, thereby avoiding unnecessary valvular manipulation and its potential hemodynamic risks. Mavacamten, a selective cardiac myosin inhibitor, represents an important advance in pharmacological management, achieving a mean LVOT gradient reduction of 37.2 mmHg in symptomatic patients. Furthermore, data from the MARVEL registry confirm the real-world clinical efficacy of mavacamten in obstructive hypertrophic cardiomyopathy, with 86% of patients successfully down-staged to NYHA functional class I–II. Although ASA serves as a viable alternative to surgery, it entails a higher risk of conduction abnormalities requiring permanent pacemaker implantation and subsequent re-intervention. Beyond classical hypertrophic SAM, this review addresses the diagnosis and management of post-mitral repair complications and non-hypertrophic variants. Optimal management and risk stratification remain an evolving field requiring a multidisciplinary Heart Team approach, leverage of advanced imaging, and adoption of novel medical therapies. Interventional strategies must be carefully tailored to maximize the efficacy-to-safety profile on an individualized patient basis.

Schlagwörter

Stichwörter der Autor:innen

alcohol septal ablationechocardiographyhypertrophic cardiomyopathyleft ventricular outflow tract obstructionmavacamtenmitral regurgitationmitral valveseptal myectomysurgical managementsystolic anterior motion

Autor:innen und Institutionen

  • Department of Cardiology, Centre Hospitalier General Victor Jousselin de Dreux, 28100 Dreux, France.
  • Emergency Department, Centre Hospitalier Régional et Universitaire de Tours, 37170 Tours, France.

ORCID-Profile: Dario Bottigliero

Zitieren

APA

Samet Bouhaik, F. Z., Monaco, I., Sedrati, M., Bouvet, A., Gervais, B., Trivelloni, V., Bencharef, Y., Sekkal, F. M., & Bottigliero, D. (2026). Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion. Journal of Cardiovascular Development and Disease, 13(8), 397. https://doi.org/10.3390/jcdd13080397

Vancouver

Samet Bouhaik FZ, Monaco I, Sedrati M, Bouvet A, Gervais B, Trivelloni V, et al. Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion. Journal of Cardiovascular Development and Disease. 2026;13(8):397. doi:10.3390/jcdd13080397

BibTeX
@article{SametBouhaik2026,
  author = {Samet Bouhaik, Fatima Zahra and Monaco, Ilenia and Sedrati, Mounia and Bouvet, Alix and Gervais, Benedicte and Trivelloni, Valeria and Bencharef, Yassine and Sekkal, Fouad Mohammed and Bottigliero, Dario},
  title = {Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2026},
  volume = {13},
  number = {8},
  pages = {397},
  doi = {10.3390/jcdd13080397}
}
Kostenlos starten →